
6.11 Delayed Data As of Mar 31 | ![]() Today’s Change | 5.39 Today|||52-Week Range 18.73 | -4.46% Year-to-Date |
Why Is Iovance Biotherapeutics (IOVA) Down 9.2% Since Last Earnings Report? Mar 30 / Zacks.com - Paid Partner Content | Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug Mar 27 / Zacks.com - Paid Partner Content |
Why Shares of Iovance Biotherapeutics Jumped Monday Mar 27 / MotleyFool.com - Paid Partner Content |
Previous close | 6.15 |
Today’s open | 6.14 |
Day’s range | 6.04 - 6.25 |
Volume | 184,844 |
Average volume (3 months) | 4,632,663 |
Market cap | $1.5B |
Earnings growth (last year) | -11.42% |
Earnings growth (this year) | +1.78% |
Earnings growth (next 5 years) | 0.00% |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 2.49 |
Today’s change | Today’s % change | |
---|---|---|
RCKTRocket Pharmaceutica... | +0.91 | +5.59% |
---- | ||
RCUSArcus Biosciences In... | +0.77 | +4.41% |
ARVNArvinas Inc | +0.47 | +1.75% |
Next reporting date | May 9, 2023 |
EPS forecast (this quarter) | -$0.57 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$395.9M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |